Can MRI Biomarkers Predict Triple-Negative Breast Cancer?

Can MRI Biomarkers Predict Triple-Negative Breast Cancer?

The purpose of this study was to investigate MRI features of triple-negative breast cancer (TNBC) compared with non-TNBC, to predict histopathological results. In the study, 26 patients with TNBC and 24 with non-TNBC who underwent multiparametric MRI of the breast on a 3 T magnet over a 10-months pe...

Full description

Bibliographic Details
Main Authors:	Giuliana Moffa, Francesca Galati, Emmanuel Collalunga, Veronica Rizzo, Endi Kripa, Giulia D’Amati, Federica Pediconi
Format:	Article
Language:	English
Published:	MDPI AG 2020-12-01
Series:	Diagnostics
Subjects:	triple-negative breast cancer 3 T MRI DWI breast cancer prognostic factors
Online Access:	https://www.mdpi.com/2075-4418/10/12/1090

Similar Items

Preoperative Staging in Breast Cancer: Intraindividual Comparison of Unenhanced MRI Combined With Digital Breast Tomosynthesis and Dynamic Contrast Enhanced-MRI
by: Veronica Rizzo, et al.
Published: (2021-05-01)

Transcriptomic analyses identify key differentially expressed genes and clinical outcomes between triple-negative and non-triple-negative breast cancer
by: Chen B, et al.
Published: (2018-12-01)

A clinicopathologic study of triple negative breast cancer
by: Vandana L Gaopande, et al.
Published: (2015-01-01)

Standard of Care and Promising New Agents for the Treatment of Mesenchymal Triple-Negative Breast Cancer
by: Silvia Mezi, et al.
Published: (2021-03-01)

Clinicopathological, therapeutic and prognostic features of the triple-negative tumors in moroccan breast cancer patients (experience of Hassan II university hospital in Fez)
by: Akasbi Yousra, et al.
Published: (2011-11-01)

Druggable Nucleolin Identifies Breast Tumours Associated with Poor Prognosis That Exhibit Different Biological Processes
by: Flora Nguyen Van Long, et al.
Published: (2018-10-01)

The role and function of SOX11 in DNA damage in triple-negative breast cancer
by: Lee, Tian Yu
Published: (2019)

Potential clinically useful prognostic biomarkers in triple-negative breast cancer: preliminary results of a retrospective analysis
by: Ilie SM, et al.
Published: (2018-11-01)

Clinical and histopathological characteristics associated with patients with triple-negative Breast cancer at a national reference hospital, 2012 - 2018
by: Giuliana Mandujano-Guizado, et al.
Published: (2019-06-01)

Metastatic Triple Negative Breast Cancer: The New Era of Thinking
by: Mohammed Amrallah A., et al.
Published: (2021-05-01)

Role of diffusion weighted images combined with breast MRI in improving the detection and differentiation of breast lesions
by: Waleed Hetta
Published: (2015-03-01)

Triple Negative Breast Cancer: A Review of Present and Future Diagnostic Modalities
by: Sylvia Annabel Dass, et al.
Published: (2021-01-01)

Genomic features of rapid versus late relapse in triple negative breast cancer
by: Yiqing Zhang, et al.
Published: (2021-05-01)

Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients
by: Silvana Anna Maria Urru, et al.
Published: (2018-01-01)

New chemotherapy options for triple-negative breast cancer (review of literature)
by: M A Sekundova, et al.
Published: (2014-03-01)

Androgen Receptor Expression and Association With Distant Disease-Free Survival in Triple Negative Breast Cancer: Analysis of 263 Patients Treated With Standard Therapy for Stage I-III Disease
by: Maria Vittoria Dieci, et al.
Published: (2019-06-01)

Clinical Initial Response of Neoadjuvant Chemotheraphy in Triple Negative, HER-2, and Luminal Types of Breast Cancer in Denpasar (A Preliminary Study)
by: Kristianto Yuli Yarso, et al.
Published: (2012-01-01)

Clinical Initial Response of Neoadjuvant Chemotheraphy in Triple Negative, HER-2, and Luminal Types of Breast Cancer in Denpasar (A Preliminary Study)
by: Kristianto Yuli Yarso, et al.
Published: (2012-01-01)

A Novel Seven Gene Signature-Based Prognostic Model to Predict Distant Metastasis of Lymph Node-Negative Triple-Negative Breast Cancer
by: Wenting Peng, et al.
Published: (2021-09-01)

Low KIBRA Expression Is Associated with Poor Prognosis in Patients with Triple-Negative Breast Cancer
by: So-Woon Kim, et al.
Published: (2021-08-01)

MicroRNAs and Triple Negative Breast Cancer
by: Marilena V. Iorio, et al.
Published: (2013-11-01)

Molecular basis of the triple negative breast cancer
by: Ayse Feyda Nursal
Published: (2015-06-01)

Prognostic significance of adipophilin expression in biopsy specimens of patients with triple‑negative breast cancer
by: Ishida, M., et al.
Published: (2022)

Androgen receptors: unclear ubiquitious mechanism or the missing key in the triple–negative breast cancer?
by: Ana Tečić-Vuger, et al.
Published: (2020-01-01)

The value of dynamic contrast-enhanced MRI in the diagnosis and management of triple-negative breast cancer
by: Heba Azzam, et al.
Published: (2020-02-01)

Triple-Negative Breast Cancer Survival in Iranian Patients
by: Mahdi Aghili, et al.
Published: (2013-08-01)

Current approaches in treatment of triple-negative breast cancer
by: Hanan Ahmed Wahba, et al.
Published: (2015-06-01)

Triple negative breast cancer: MRI features in comparison to other breast cancer subtypes with correlation to prognostic pathologic factors
by: Noha Mohamed Osman, et al.
Published: (2014-12-01)

High Expression of microRNA-223 Indicates a Good Prognosis in Triple-Negative Breast Cancer
by: Li Chen, et al.
Published: (2021-04-01)

The value of dynamic contrast-enhanced MRI in differentiating triple-negative breast cancer from other subtypes
by: Heba Azzam, et al.
Published: (2019-12-01)

The efficacy of neoadjuvant chemotherapy and survival in older patients with stages II to III triple-negative breast cancer
by: Olga O Gordeeva, et al.
Published: (2019-09-01)

Efficacy and safety of cisplatin and paclitaxel (PlaTax regimen) in the neoadjuvant treatment of patients with stage II–III triple-negative breast cancer
by: O. O. Gordeeva, et al.
Published: (2020-11-01)

Focus on Triple-Negative Breast Cancer: Potassium Channel Expression and Clinical Correlates
by: Elena Lastraioli
Published: (2020-05-01)

The Effect of Everolimus in an In Vitro Model of Triple Negative Breast Cancer and Osteoclasts
by: Laura Mercatali, et al.
Published: (2016-11-01)

Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer
by: Yuka Asano, et al.
Published: (2017-01-01)

AJCC 8th edition prognostic staging provides no better discriminatory ability in prognosis than anatomical staging in triple negative breast cancer
by: Jiehua He, et al.
Published: (2020-01-01)

Orbital Metastasis from Triple-Negative Breast Cancer: Case Report and Literature Review
by: Kamal El Bakraoui, et al.
Published: (2020-09-01)

Triple negative breast cancer and platinum-based systemic treatment: a meta-analysis and systematic review
by: Jessa Gilda P. Pandy, et al.
Published: (2019-11-01)

Nectin-4 Expression Is an Independent Prognostic Biomarker and Associated With Better Survival in Triple-Negative Breast Cancer
by: Jasmin Zeindler, et al.
Published: (2019-09-01)

The Obesity Paradox in Cancer, Tumor Immunology, and Immunotherapy: Potential Therapeutic Implications in Triple Negative Breast Cancer
by: Adviti Naik, et al.
Published: (2019-08-01)